Innovative drug stocks plummeted as reports emerged that the Trump administration was preparing an executive order targeting Chinese pharmaceuticals.

2025-09-11 10:30:09

Innovative drug stocks plummeted in early trading today (September 11th), with CXO-related, weight loss, and innovative drug concepts all falling by over 1%. Even leading innovative drug companies with a market value exceeding 100 billion yuan were not immune to the correction, with BeiGene-U and Hengrui Medicine both falling by over 5%. On the news front, it was reported that the Trump administration is considering an executive order targeting Chinese pharmaceuticals.

weight loss drug BeiGene

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Musk: XAI will certainly raise funds in the next few months, but not now
                            2025-09-20

                                    Nvidia (NVDA.O) fell further, dropping nearly 3%.
                            2025-09-17

                                    SoftBank and OpenAI's AI joint venture in Japan is severely delayed, with an update now expected in November.
                            2025-09-18

                                    HGTECH's 3.2T NPO products are used by leading industry customers
                            2025-09-24

                                    Alipay's two operating entities have completed the name change
                            2025-09-19